Listed

Creative Medical Technology Holdings, Inc.: Form 10-Q for the period ended Jun 30, 2021

Filed with the SEC on Aug 16, 2021 and accepted by EDGAR at Aug 16, 2021, 16:46 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-04-01 to 2021-06-30$10.0kus-gaap:Revenues
Revenue6 months2021-01-01 to 2021-06-30$10.0kus-gaap:Revenues
Cost of revenue3 months2021-04-01 to 2021-06-30$4.5kus-gaap:CostOfRevenue
Cost of revenue6 months2021-01-01 to 2021-06-30$4.5kus-gaap:CostOfRevenue
Gross profit3 months2021-04-01 to 2021-06-30$5.5kus-gaap:GrossProfit
Gross profit6 months2021-01-01 to 2021-06-30$5.5kus-gaap:GrossProfit
Selling, general and administrative3 months2021-04-01 to 2021-06-30$498.3kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2021-01-01 to 2021-06-30$779.2kus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-04-01 to 2021-06-30−$515.8kus-gaap:OperatingIncomeLoss
Operating income6 months2021-01-01 to 2021-06-30−$819.8kus-gaap:OperatingIncomeLoss
Interest expense3 months2021-04-01 to 2021-06-30$234.3kus-gaap:InterestExpense
Interest expense6 months2021-01-01 to 2021-06-30$570.4kus-gaap:InterestExpense
Net income3 months2021-04-01 to 2021-06-30−$2.9mus-gaap:NetIncomeLoss
Net income6 months2021-01-01 to 2021-06-30$24.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-04-01 to 2021-06-30$0.00us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2021-01-01 to 2021-06-30$0.02us-gaap:EarningsPerShareDiluted
Diluted shares (weighted)6 months2021-01-01 to 2021-06-301,164,463,648 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2021-01-01 to 2021-06-30−$663.7kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2021-06-30$158.6kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-06-30$158.6kus-gaap:AssetsCurrent
Total assetsAt period end2021-06-30$732.3kus-gaap:Assets
Current liabilitiesAt period end2021-06-30$1.4mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2021-06-30$342.5kus-gaap:LongTermDebt
Shareholders' equityAt period end2021-06-30−$714.5kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001477932-21-005614. Last ingested by Listed: Nov 14, 2026, 19:08 ET. Listed shows no prices and gives no investment advice.